Position in RPRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$299,194,229
+$167,270,894 QoQ
Shares Held
5,336,084
+56.3% QoQ
Ownership
0.928%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#12
of 635 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. RPRX ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
This page
|
5,336,084 | $299,194,229 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $299,194,229 | 5,336,084 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $131,923,335 | 3,414,165 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $181,388,315 | 5,034,369 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $152,344,492 | 4,893,816 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $124,497,626 | 4,880,346 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $136,056,313 | 4,809,343 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $126,822,374 | 4,809,343 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $136,666,852 | 4,500,061 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $119,740,254 | 4,262,736 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $112,260,186 | 4,136,337 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $125,946,421 | 4,097,151 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $157,368,519 | 4,367,708 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $150,822,428 | 3,816,357 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $140,533,728 | 3,497,604 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $142,662,613 | 3,393,497 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $119,661,588 | 3,071,396 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $117,965,564 | 2,960,240 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $103,386,782 | 2,860,730 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $114,565,082 | 2,794,952 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $120,528,035 | 2,763,137 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $51,179,678 | 1,022,571 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $30,389,811 | 722,363 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $111,786,763 | 2,302,508 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||